DOXIPHLEX

This brand name is authorized in Nigeria.

Active ingredients

The drug DOXIPHLEX contains one active pharmaceutical ingredient (API):

1	Cefalexin UNII OBN7UDS42Y - CEPHALEXIN
	Cefalexin is an antibacterial agent of the cephalosporin class. Like other cephalosporins cefalexin exerts antibacterial activity by binding to and inhibiting the action of penicillin-binding proteins involved in the synthesis of bacterial cell walls. This leads to bacterial cell lysis and cell death.
	Read more about Cefalexin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-0243	Powder for suspension	DOXIPHLEX POWDER FOR ORAL SUSPENSION 125MG PWD_F_SOL 125 mg 100ml	DOXIPHLEX POWDER FOR ORAL SUSPENSION 125MG C4-0243 DOXIPHLEX CEPHALEXIN ANTIBIOTICS ORAL 125MG ORAL SUSPENSION PRESCRIPTION ONLY MEDICINE (POM) TREATMENT OF INFECTIONS CAUSED BY SUSCEPTIBLE MICRO-ORGANISMS DOVIZIA PHARMA SERVICES LIMITED NIGERIA ASSOCIATED BIOTECH INDIA 2019-12-20 2024-12-19 NO ACTIVE INGREDIENT	20/12/2019

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DB01	Cefalexin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DB First-generation cephalosporins
Discover more medicines within J01DB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-0243